Fariello, RG (1998). «Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease». Drugs. 55 (Suppl 1): 10–6. PMID9483165. doi:10.2165/00003495-199855001-00002
Fariello, RG (1998). «Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease». Drugs. 55 (Suppl 1): 10–6. PMID9483165. doi:10.2165/00003495-199855001-00002